BDX
BD BECTON DICKINSON & CO
+1.86 (+1.02%)183.71USD477K成交股數50.0B市值55.5本益比(近四季)2.2股價營收比+5.4%營收年增(近四季)2026-11-05下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 6 · 1.4M · 4 |
| 其中 10b5-1 計畫賣出 | 5 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 2.0M |
| 近 180 天 淨額 | −2.0M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-02 | 09-03 | Roque Vitor | EVP & Chief Financial Officer | F 繳稅扣股 | 190 | – | – | 8.0K | SEC |
| 2026-08-26 | 08-27 | Feld Michael | EVP, Chief Revenue Officer | S 公開市場賣出(10b5-1) | 165 | 188.49 | 31K | 19.7K | SEC |
| 2026-08-20 | 08-24 | Feld Michael | EVP, Chief Revenue Officer | F 繳稅扣股 | 1.0K | – | – | 19.9K | SEC |
| 2026-08-13 | 08-14 | Polen Thomas E Jr | Chairman, CEO and President | M 選擇權執行 | 43.3K | 167.25 | 7.2M | 153K | SEC |
| 2026-08-13 | 08-14 | Polen Thomas E Jr | Chairman, CEO and President | D 處分 | 39.1K | 185.00 | 7.2M | 114K | SEC |
| 2026-08-13 | 08-14 | Polen Thomas E Jr | Chairman, CEO and President | S 公開市場賣出(10b5-1) | 4.2K | 185.00 | 768K | 110K | SEC |
| 2026-08-11 | 08-12 | Goette Roland | EVP and President, EMEA | S 公開市場賣出 | 2.4K | 180.84 | 441K | 14.9K | SEC |
| 2026-07-27 | 07-28 | Feld Michael | EVP, Chief Revenue Officer | S 公開市場賣出(10b5-1) | 75 | 157.13 | 12K | 20.9K | SEC |
| 2026-07-02 | 07-06 | Muhsin Bilal | EVP & President Connected Care | F 繳稅扣股 | 1.9K | – | – | 41.4K | SEC |
| 2026-07-01 | 07-06 | Muhsin Bilal | EVP & President Connected Care | A 獲配股票 | 14.3K | – | – | 43.3K | SEC |
| 2026-06-26 | 06-26 | Feld Michael | EVP, Chief Revenue Officer | S 公開市場賣出(10b5-1) | 75 | 152.80 | 11K | 21.0K | SEC |
| 2026-06-24 | 06-25 | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | S 公開市場賣出(10b5-1) | 1.1K | 145.66 | 160K | 13.2K | SEC |
| 2026-06-10 | 06-11 | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | S 公開市場賣出(10b5-1) | 1.1K | 151.48 | 167K | 14.3K | SEC |
| 2026-06-01 | 06-03 | Polen Thomas E Jr | Chairman, CEO and President | D 處分 | 17.4K | 146.15 | 2.5M | 108K | SEC |
| 2026-06-01 | 06-03 | Polen Thomas E Jr | Chairman, CEO and President | M 選擇權執行 | 20.2K | 126.16 | 2.5M | 126K | SEC |
| 2026-06-01 | 06-03 | Polen Thomas E Jr | Chairman, CEO and President | S 公開市場賣出(10b5-1) | 2.8K | 146.35 | 405K | 110K | SEC |
| 2026-06-01 | 06-02 | Menziuso Peter | EVP and President, BDI | A 獲配股票 | 14.3K | – | – | 14.3K | SEC |
| 2026-05-26 | 05-27 | Feld Michael | EVP, Chief Revenue Officer | S 公開市場賣出(10b5-1) | 75 | 147.35 | 11K | 21.1K | SEC |
| 2026-05-07 | 05-08 | Roque Vitor | EVP & Chief Financial Officer | A 獲配股票 | 1.7K | – | – | 8.2K | SEC |
| 2026-04-27 | 04-28 | Feld Michael | EVP, Chief Revenue Officer | S 公開市場賣出(10b5-1) | 74 | 151.94 | 11K | 21.2K | SEC |
| 2026-04-06 | 04-06 | Neal Shana Carol | EVP and Chief People Officer | F 繳稅扣股 | 1.1K | – | – | 24.0K | SEC |
| 2026-03-26 | 03-27 | Feld Michael | EVP, Chief Revenue Officer | S 公開市場賣出(10b5-1) | 75 | 156.83 | 12K | 21.2K | SEC |
| 2026-03-16 | 03-17 | Minnix Lanesha | EVP and General Counsel | A 獲配股票 | 7.5K | – | – | 7.5K | SEC |
| 2026-03-02 | 03-04 | Roque Vitor | Interim CFO | A 獲配股票 | 931 | – | – | 6.5K | SEC |
| 2026-03-02 | 03-04 | Spikner Pamela L. | SVP Controller & CAO | A 獲配股票 | 931 | – | – | 3.3K | SEC |
| 2026-02-26 | 02-27 | Feld Michael | EVP, Chief Revenue Officer | S 公開市場賣出(10b5-1) | 75 | 181.84 | 14K | 21.3K | SEC |
| 2026-02-18 | 02-18 | SCOTT BERTRAM L | Director | S 公開市場賣出 | 953 | 182.61 | 174K | 36.8K | SEC |
| 2026-01-27 | 01-29 | SCOTT BERTRAM L | Director | A 獲配股票 | 1.1K | – | – | 37.7K | SEC |
| 2026-01-27 | 01-29 | RING TIMOTHY M | Director | A 獲配股票 | 1.1K | – | – | 59.2K | SEC |
| 2026-01-27 | 01-29 | Waldstreicher Joanne | Director | A 獲配股票 | 1.1K | – | – | 3.4K | SEC |
| 2026-01-27 | 01-29 | Wright Jacqueline | Director | A 獲配股票 | 1.1K | – | – | 1.3K | SEC |
| 2026-01-27 | 01-29 | Jones Christopher Ian Montague | Director | A 獲配股票 | 1.1K | – | – | 24.3K | SEC |
| 2026-01-27 | 01-29 | Huffines Robert Luther | Director | A 獲配股票 | 1.1K | – | – | 1.3K | SEC |
| 2026-01-27 | 01-29 | Byington Carrie L | Director | A 獲配股票 | 1.1K | – | – | 5.0K | SEC |
| 2026-01-27 | 01-29 | ECKERT R ANDREW | Director | A 獲配股票 | 1.1K | – | – | 10.4K | SEC |
| 2026-01-27 | 01-29 | Henderson Jeffrey William | Director | A 獲配股票 | 1.1K | – | – | 9.1K | SEC |
| 2026-01-27 | 01-29 | HAYES GREGORY | Director | A 獲配股票 | 1.1K | – | – | 7.2K | SEC |
| 2026-01-27 | 01-29 | Brown William M | Director | A 獲配股票 | 1.1K | – | – | 4.7K | SEC |
| 2026-01-26 | 01-28 | Feld Michael | EVP, CRO & Pres. Life Sciences | S 公開市場賣出(10b5-1) | 75 | 202.73 | 15K | 16.4K | SEC |
| 2026-01-21 | 01-23 | Spikner Pamela L. | SVP Controller & CAO | F 繳稅扣股 | 84 | – | – | 1.8K | SEC |
| 2026-01-15 | 01-16 | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | D 處分 | 2.5K | 209.00 | 513K | 13.7K | SEC |
| 2026-01-15 | 01-16 | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | S 公開市場賣出(10b5-1) | 1.0K | 206.54 | 209K | 12.1K | SEC |
| 2026-01-15 | 01-16 | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | M 選擇權執行 | 3.1K | 167.91 | 513K | 16.2K | SEC |
| 2026-01-15 | 01-16 | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | S 公開市場賣出(10b5-1) | 600 | 209.00 | 125K | 13.1K | SEC |
| 2026-01-03 | 01-06 | Shan David | EVP and Chief ISC Officer | F 繳稅扣股 | 44 | – | – | 8.9K | SEC |
| 2025-12-26 | 12-29 | Feld Michael | EVP, CRO & Pres. Life Sciences | S 公開市場賣出(10b5-1) | 74 | 196.08 | 15K | 16.5K | SEC |
| 2025-12-17 | 12-17 | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | S 公開市場賣出(10b5-1) | 629 | 196.03 | 123K | 13.1K | SEC |
| 2025-12-01 | 12-02 | Huffines Robert Luther | Director | A 獲配股票 | 180 | – | – | 180 | SEC |
| 2025-12-01 | 12-02 | Wright Jacqueline | Director | A 獲配股票 | 180 | – | – | 180 | SEC |
| 2025-12-01 | 12-02 | Feld Michael | EVP, CRO & Pres. Life Sciences | S 公開市場賣出(10b5-1) | 75 | 193.36 | 15K | 16.6K | SEC |
| 2025-11-26 | 12-01 | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | A 獲配股票 | 7.6K | – | – | 12.5K | SEC |
| 2025-11-26 | 12-01 | Feld Michael | EVP, CRO & Pres. Life Sciences | F 繳稅扣股 | 419 | – | – | 16.7K | SEC |
| 2025-11-26 | 12-01 | Feld Michael | EVP, CRO & Pres. Life Sciences | A 獲配股票 | 8.8K | – | – | 17.1K | SEC |
| 2025-11-26 | 12-01 | DelOrefice Christopher | EVP & Chief Financial Officer | A 獲配股票 | 6.0K | – | – | 27.2K | SEC |
| 2025-11-26 | 12-01 | Byrd Richard | EVP & President Interventional | F 繳稅扣股 | 1.7K | – | – | 13.8K | SEC |
| 2025-11-26 | 12-01 | Byrd Richard | EVP & President Interventional | A 獲配股票 | 2.4K | – | – | 15.6K | SEC |
| 2025-11-26 | 12-01 | Byrd Richard | EVP & President Interventional | A 獲配股票 | 6.4K | – | – | 13.2K | SEC |
| 2025-11-26 | 12-01 | DelOrefice Christopher | EVP & Chief Financial Officer | F 繳稅扣股 | 4.2K | – | – | 23.0K | SEC |
| 2025-11-26 | 12-01 | Muhsin Bilal | EVP & President Connected Care | A 獲配股票 | 9.5K | – | – | 21.8K | SEC |
| 2025-11-26 | 12-01 | Polen Thomas E Jr | Chairman, CEO and President | F 繳稅扣股 | 17.4K | – | – | 105K | SEC |
| 2025-11-26 | 12-01 | Polen Thomas E Jr | Chairman, CEO and President | A 獲配股票 | 22.5K | – | – | 123K | SEC |
| 2025-11-26 | 12-01 | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | A 獲配股票 | 3.0K | – | – | 15.5K | SEC |
| 2025-11-26 | 12-01 | Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | F 繳稅扣股 | 1.8K | – | – | 13.7K | SEC |
| 2025-11-26 | 12-01 | Shan David | EVP and Chief ISC Officer | A 獲配股票 | 1.0K | – | – | 9.1K | SEC |
| 2025-11-26 | 12-01 | Spikner Pamela L. | SVPController & Chief Acct Off | A 獲配股票 | 1.2K | – | – | 1.9K | SEC |
| 2025-11-26 | 12-01 | Mocherla Pavan Kumar | EVP & President, Greater Asia | A 獲配股票 | 2.2K | – | – | 5.1K | SEC |
| 2025-11-26 | 12-01 | Shan David | EVP and Chief ISC Officer | F 繳稅扣股 | 134 | – | – | 9.0K | SEC |
| 2025-11-26 | 12-01 | Goette Roland | EVP and President, EMEA | A 獲配股票 | 1.9K | – | – | 16.1K | SEC |
| 2025-11-26 | 12-01 | Shan David | EVP and Chief ISC Officer | A 獲配股票 | 3.5K | – | – | 8.1K | SEC |
| 2025-11-26 | 12-01 | Neal Shana Carol | EVP and Chief People Officer | F 繳稅扣股 | 2.5K | – | – | 21.3K | SEC |
| 2025-11-26 | 12-01 | Neal Shana Carol | EVP and Chief People Officer | A 獲配股票 | 3.5K | – | – | 23.8K | SEC |
| 2025-11-26 | 12-01 | Neal Shana Carol | EVP and Chief People Officer | A 獲配股票 | 6.7K | – | – | 20.3K | SEC |
| 2025-11-26 | 12-01 | Goette Roland | EVP and President, EMEA | F 繳稅扣股 | 138 | – | – | 17.2K | SEC |
| 2025-11-26 | 12-01 | Mocherla Pavan Kumar | EVP & President, Greater Asia | A 獲配股票 | 708 | – | – | 5.8K | SEC |
| 2025-11-26 | 12-01 | Goette Roland | EVP and President, EMEA | A 獲配股票 | 1.2K | – | – | 17.4K | SEC |
| 2025-11-07 | 11-07 | SCOTT BERTRAM L | Director | S 公開市場賣出 | 217 | 176.58 | 38K | 35.8K | SEC |
| 2025-10-27 | 10-28 | Feld Michael | EVP & President, Life Sciences | S 公開市場賣出(10b5-1) | 57 | 186.01 | 11K | 8.2K | SEC |
| 2025-09-26 | 09-29 | Feld Michael | EVP & President, Life Sciences | S 公開市場賣出(10b5-1) | 58 | 181.03 | 10K | 8.3K | SEC |
| 2025-09-10 | 09-11 | Fraser Claire | Director | S 公開市場賣出 | 917 | 187.50 | 172K | 22.2K | SEC |
| 2025-09-01 | 09-02 | Byrd Richard | EVP & President Interventional | F 繳稅扣股 | 216 | – | – | 6.7K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| First Eagle Investment Management, LLC | 27.6M | 4.2B | 新進 | 新進 |
| BlackRock, Inc. | 24.6M | 3.7B | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 18.0M | 2.7B | 新進 | 新進 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 8.7M | 2.5B | 新進 | 新進 |
| STATE STREET CORP | 15.0M | 2.3B | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 15.0M | 2.3B | 新進 | 新進 |
| Invesco Ltd. | 8.9M | 1.3B | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 8.1M | 1.2B | 新進 | 新進 |
| FRANKLIN RESOURCES INC | 7.0M | 1.1B | 新進 | 新進 |
| WELLINGTON MANAGEMENT GROUP LLP | 6.4M | 962M | 新進 | 新進 |
| GREENHAVEN ASSOCIATES INC | 5.7M | 860M | 新進 | 新進 |
| 挪威主權基金 NORGES BANK | 4.2M | 631M | 新進 | 新進 |
| AMERICAN CENTURY COMPANIES INC | 3.7M | 556M | 新進 | 新進 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 3.4M | 515M | 新進 | 新進 |
| MORGAN STANLEY | 3.3M | 502M | 新進 | 新進 |
| Clearbridge Investments, LLC | 3.2M | 489M | 新進 | 新進 |
| BANK OF AMERICA CORP /DE/ | 3.1M | 475M | 新進 | 新進 |
| JPMORGAN CHASE & CO | 2.8M | 440M | 新進 | 新進 |
| NORTHERN TRUST CORP | 2.6M | 397M | 新進 | 新進 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2.5M | 385M | 新進 | 新進 |
| HARRIS ASSOCIATES L P | 2.4M | 356M | 新進 | 新進 |
| DIMENSIONAL FUND ADVISORS LP | 2.1M | 324M | 新進 | 新進 |
| First Pacific Advisors, LP | 2.1M | 319M | 新進 | 新進 |
| Legal & General Group Plc | 2.1M | 318M | 新進 | 新進 |
| Amundi | 1.8M | 275M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 1,436 -39 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 1436 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 278M · 100.0% |
| 合計季末市值 | 41.1B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 10.7M |
|---|---|
| 與上期比 | +13.9% |
| 佔流通股數 | 3.92% |
| 日均成交量 | 1.7M |
| 回補天數 | 6.1 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 10.7M | +13.9% | 3.92% | 1.7M | 6.1 |
| 2026-08-14 | 9.4M | -6.5% | 3.44% | 2.0M | 4.8 |
| 2026-07-31 | 10.0M | -3.5% | 3.68% | 1.7M | 5.7 |
| 2026-07-15 | 10.4M | -7.6% | 3.81% | 1.8M | 5.8 |
| 2026-06-30 | 11.2M | +54.4% | 4.13% | 3.9M | 2.9 |
| 2026-06-15 | 7.3M | +1.0% | 2.67% | 2.0M | 3.6 |
| 2026-05-29 | 7.2M | -14.4% | 2.64% | 3.0M | 2.4 |
| 2026-05-15 | 8.4M | +31.9% | 3.09% | 3.7M | 2.3 |
| 2026-04-30 | 6.4M | -11.6% | 2.34% | 3.1M | 2.1 |
| 2026-04-15 | 7.2M | -24.0% | 2.65% | 2.5M | 2.9 |
| 2026-03-31 | 9.5M | -17.2% | 3.48% | 2.3M | 4.2 |
| 2026-03-13 | 11.5M | -16.8% | 4.21% | 2.7M | 4.3 |
| 2026-02-27 | 13.8M | -5.3% | 5.06% | 2.9M | 4.7 |
| 2026-02-13 | 14.6M | +117.5% | 5.34% | 3.9M | 3.8 |
| 2026-01-30 | 6.7M | +10.3% | 2.46% | 1.9M | 3.5 |
| 2026-01-15 | 6.1M | +0.7% | 2.23% | 1.7M | 3.6 |
| 2025-12-31 | 6.0M | +25.4% | 2.21% | 1.9M | 3.2 |
| 2025-12-15 | 4.8M | +0.3% | 1.77% | 2.0M | 2.5 |
| 2025-11-28 | 4.8M | +14.7% | 1.76% | 2.0M | 2.4 |
| 2025-11-14 | 4.2M | +34.2% | 1.53% | 3.6M | 1.2 |
| 2025-10-31 | 3.1M | -5.1% | 1.14% | 2.1M | 1.5 |
| 2025-10-15 | 3.3M | -14.4% | 1.20% | 1.2M | 2.8 |
| 2025-09-30 | 3.8M | -10.5% | 1.41% | 1.4M | 2.7 |
| 2025-09-15 | 4.3M | -6.1% | 1.57% | 1.8M | 2.4 |
| 2025-08-29 | 4.6M | -11.9% | 1.67% | 1.7M | 2.7 |
| 2025-08-15 | 5.2M | -5.5% | 1.90% | 3.3M | 1.6 |